Larimar Therapeutics Inc
Analysts review Larimar Therapeutics Inc’s rating
Larimar Therapeutics Inc’s recent filing unveils that its Director Flynn James E acquired Company’s shares for reported $30.0 million on ...
Examining the Potential Price Growth of Larimar Therapeutics Inc (LRMR)
In a filing, Larimar Therapeutics Inc revealed its Director Flynn James E acquired Company’s shares for reported $30.0 million on ...
Larimar Therapeutics Inc [LRMR] Investment Guide: What You Need to Know
Larimar Therapeutics Inc’s filing revealed that its Director Flynn James E acquired Company’s shares for reported $30.0 million on Jul ...
Checking in on Larimar Therapeutics Inc (LRMR) after recent insiders movement
In a filing, Larimar Therapeutics Inc revealed its Director Flynn James E acquired Company’s shares for reported $30.0 million on ...
Truist’s latest rating for LRMR stock
Larimar Therapeutics Inc’s recent filing unveils that its Director Flynn James E acquired Company’s shares for reported $30.0 million on ...
Understanding the Risks of Investing in Larimar Therapeutics Inc (LRMR)
Larimar Therapeutics Inc’s filing revealed that its Director Flynn James E acquired Company’s shares for reported $30.0 million on Jul ...
Larimar Therapeutics Inc [LRMR] Investment Guide: What You Need to Know
Larimar Therapeutics Inc’s filing revealed that its Director Flynn James E acquired Company’s shares for reported $30.0 million on Jul ...
